Patient Rating:

No Rating Available?

Kimberly E. Hanson, M.D., M.H.S.

Patient Rating:

No Rating Available?

Specialties

Languages

  • English

Clinical Details

Schedule An Appointment Clinical Office Address
(801) 585-2031 University Hospital
Infectious Diseases, Clinic 1A
50 N Medical Dr
Salt Lake City, UT 84132
Map

Specialties

Bio

Kimberly Hanson, MD, MHS is a board certified pysician in Adult Infectious Diseases and Medical Microbiology. She has specialized expertise in the diagnosis and management of opportunistic viral, fungal and mycobacterial diseases. Her primary clinical focus is transplant and cancer chemotherapy-related infections.

Board Certification and Academic Information

Academic Departments Internal Medicine - Associate Professor
Pathology - Adjunct Assistant Professor
Academic Divisions Infectious Diseases
Board Certification American Board of Internal Medicine (Sub: Infec Disease)
American Board of Pathology (Sub: Med Microbiology)

Academic Profile

Research Interests

  • Cytomegalovirus Infections
  • Aspergillosis
  • Diagnostics Assays

Board Certification and Academic Information

Academic Departments Internal Medicine - Associate Professor
Pathology - Adjunct Assistant Professor
Academic Divisions Infectious Diseases
Board Certification American Board of Internal Medicine (Sub: Infec Disease)
American Board of Pathology (Sub: Med Microbiology)

Academic Office Locations

Academic Office Phone Number Academic Office Address
School of Medicine
Infectious Disease
30 N Medical Dr
Salt Lake City, UT 84132

Academic Bio

Dr. Kimberly Hanson is the Head of Immuncompromised Host Infectious Diseases Services at the University Hospital and Huntsman Cancer Center as well as Director of Clinical Microbiology within ARUP Laboratories. She is an Associate Professor of Medicine and Pathology, splitting her time between patient care, laboratory administration, research and teaching. Dr. Hanson was recruited to the University of Utah in 2008 from Duke University, where she obtained specialty training in Adult Infectious Diseases, Medical Microbiology and Health Sciences Research. She maintains an active research program that is focused on the development and validation of novel, cost-effective diagnostic tests for Infectious Diseases. Dr. Hanson has authored over 30 scientific papers, book chapters and review articles with a focus on transplant-related infectious diseases and clinical diagnostics. As the Medical Microbiology Fellowship Program Director, she is also actively involved in the training of medical students, residents and fellows within the University’s School of Medicine.

Education

Education History

Type School Degree
Graduate Training Duke University Medical Center
Health Sciences
Master's
Fellowship Duke University Medical Center
Medical Microbiology
Fellow
Fellowship Duke University Medical Center
Infectious Disease
Fellow
Chief Resident Dartmouth Hitchcock Medical Center
Internal Medicine
Chief Medical Resident
Residency Dartmouth Hitchcock Medical Center
Internal Medicine
Resident
Internship Dartmouth Hitchcock Medical Center
Internal Medicine
Intern
Professional Medical Northwestern University Medical School
Medicine
M.D.
Undergraduate Northwestern University
Anthropology
B.A.

Publications

Selected Provider Publications

Journal Article

  1. Hansen J, Slechta ES, Gates-Hollingsworth MA, Neary B, Barker AP, Bauman S, Kozel TR, Hanson KE (2013). Large-scale evaluation of the immuno-mycologics lateral flow and enzyme-linked immunoassays for detection of cryptococcal antigen in serum and cerebrospinal fluid. Clin Vaccine Immunol, 20(1), 52-5.
  2. Slechta ES, Hohmann SL, Simmon K, Hanson KE (2012). Internal transcribed spacer region sequence analysis using SmartGene IDNS software for the identification of unusual clinical yeast isolates. Med Mycol, 50(5), 458-66.
  3. Couturier MR, Slechta ES, Goulston C, Fisher MA, Hanson KE (2012). Leptotrichia bacteremia in patients receiving high-dose chemotherapy. J Clin Microbiol, 50(4), 1228-32.
  4. Kim JH, Goulston C, Sanders S, Lampas M, Zangari M, Tricot G, Hanson KE (2012). Cytomegalovirus reactivation following autologous peripheral blood stem cell transplantation for multiple myeloma in the era of novel chemotherapeutics and tandem transplantation. Biol Blood Marrow Transplant, 18(11), 1753-8.
  5. Hanson KE, Pfeiffer CD, Lease ED, Balch AH, Zaas AK, Perfect JR, Alexander BD (2012). beta-D-glucan Surveillance with Preemptive Anidulafungin for Invasive Candidiasis in Intensive Care Unit Patients: A Randomized Pilot Study. PLoS One, 7(8), e42282.
  6. Ravkov EV, Pavlov IY, Hanson KE, Delgado JC (2012). Validation of cytomegalovirus immune competence assays for the characterization of CD8(+) T cell responses posttransplant. Clin Dev Immunol, 2012, 451059.

Abstract

  1. Barker A, Siady S, Slechta ES, Cohen S, Hanson KE (2012). Differentiation of the Mycobacterium tuberculosis complex using Matrix Assisted Laser Ion Desorption Time of Flight Mass Spectroscopy [Abstract]. 112th General Meeting of the American Society for Microbiology. June 2012. San Fransisco, CA.
  2. Hansen J, Barker A, Johnson S, Quinones K, Slechta ES, Neary B, Bauman S, Hanson KE (2012). Evaluation of a Newly Developed Lateral Flow and Enzyme-linked Immunoassay for the Detection of Cryptococcal Antigen [Abstract]. 112th General Meeting of the American Society for Microbiology. June 2012. San Francisco, CA.
  3. Hansen J, Slechta ES, Neary B, Gates-Hollingworth M, Barker A, Sean Bauman, Kozel T and Hanson, KE (2012). Evaluation of the Immuno-Mycologics Inc. (IMMY) Lateral Flow and Enzyme-linked Immunoassays for the detection of Cryptococcal Antigen in Serum and Cerebrospinal Fluid [Abstract]. 112th General Meeting of the American Society for Microbiology. June 2012. San Fransisco, CA.
  4. Kendall BA, Slechta SE, Simmon KE, Muir H, Hanson KE (2012). Utility of a Novel 16S Sequence Analysis Software for the Evaluation of Polymicrobial AFB Cultures: Results of a 1 year Pilot Study in a Clinical Laboratory [Abstract]. 112th General Meeting of the American Society for Microbiology. June 2012. San Francisco, CA.

Clinical Trials

Video & News

Video